Loading...
OTCM
BFNH
Market cap16mUSD
Dec 05, Last price  
0.49USD
1D
-13.76%
1Q
-39.90%
IPO
-97.14%
Name

BioForce Nanosciences Holdings Inc

Chart & Performance

D1W1MN
OTCM:BFNH chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
13.91%
Rev. gr., 5y
-63.44%
Revenues
0k
0415,0871,125,030026,71206,0758,2504,50016,31017,77500000
Net income
-490k
L+3.92%
-19,221-3,974,083-3,854,206-4,30122,161-2,500-2,500-2,500-31,261-67,738-46,538-158,408,555-501,955-485,514-471,953-490,437
CFO
-61k
L+31.15%
0-2,655,003-2,747,933022,16100-3,212-25,898-62,466-24,383-80,196-77,772-68,389-46,702-61,250

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, and mass merchandisers under the BioForce Eclipse brand, as well as through online and telemarketing. The company is based in Virginia Beach, Virginia.
IPO date
Oct 11, 2005
Employees
3
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT